To include your compound in the COVID-19 Resource Center, submit it here.

Truvada emtricitabine/tenofovir: Phase III data

The University of Washington's International Clinical Research Center reported preliminary data from the double-blind, Kenyan and Ugandan Phase III Partners PrEP trial in 4,758 heterosexual couples of which 1 member was infected with HIV showing that pre-exposure prophylaxis with either once-daily 300 mg oral

Read the full 449 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers